Labeling of Highly Enriched Populations of Primitive and Mature Hemopoietic Stem Cells and Progenitor Cells
125I-Cytokine . | Primitive HSC* Rhlolin−Sca-1+c-kit+ . | Mature HSC* Rhhilin−Sca-1+c-kit+ . | Progenitors* lin−Sca-1−c-kit+ . | ||||||
---|---|---|---|---|---|---|---|---|---|
. | % Cells Labeled . | Av Grains/Labeled Cell‡ . | Receptors/Labeled Cell . | % Cells Labeled . | Av Grains/Labeled Cell‡ . | Receptors/Labeled Cell . | % Cells Labeled . | Av Grains/Labeled Cell‡ . | Receptors/Labeled Cell . |
rr′ SCF | † | † | 17† | 21 ± 29 | 960 | ||||
rh M-CSF | 3 | 30 ± 29 | 90 | 0 | 0 | 0 | 0 | 0 | 0 |
rm IL-3 | 65 | 16 ± 12 | 80 | 69 | 24 ± 15 | 110 | 93 | 24 ± 24 | 110 |
rm GM-CSF | 0 | 0 | 0 | 3 | 6 ± 4 | 190 | 55 | 18 ± 14 | 560 |
nm G-CSF | 79 | 22 ± 21 | 60 | 73 | 30 ± 22 | 80 | 93 | 10 ± 11 | 30 |
rm IL-6 | 13 | 10 ± 2 | 170 | 18 | 10 ± 5 | 170 | 22 | 24 ± 14 | 400 |
rh LIF | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 ± 1 | 30 |
rh IL-1α | 56 | 5 ± 2 | nd | 64 | 17 ± 11 | nd | 43 | 6 ± 3 | nd |
125I-Cytokine . | Primitive HSC* Rhlolin−Sca-1+c-kit+ . | Mature HSC* Rhhilin−Sca-1+c-kit+ . | Progenitors* lin−Sca-1−c-kit+ . | ||||||
---|---|---|---|---|---|---|---|---|---|
. | % Cells Labeled . | Av Grains/Labeled Cell‡ . | Receptors/Labeled Cell . | % Cells Labeled . | Av Grains/Labeled Cell‡ . | Receptors/Labeled Cell . | % Cells Labeled . | Av Grains/Labeled Cell‡ . | Receptors/Labeled Cell . |
rr′ SCF | † | † | 17† | 21 ± 29 | 960 | ||||
rh M-CSF | 3 | 30 ± 29 | 90 | 0 | 0 | 0 | 0 | 0 | 0 |
rm IL-3 | 65 | 16 ± 12 | 80 | 69 | 24 ± 15 | 110 | 93 | 24 ± 24 | 110 |
rm GM-CSF | 0 | 0 | 0 | 3 | 6 ± 4 | 190 | 55 | 18 ± 14 | 560 |
nm G-CSF | 79 | 22 ± 21 | 60 | 73 | 30 ± 22 | 80 | 93 | 10 ± 11 | 30 |
rm IL-6 | 13 | 10 ± 2 | 170 | 18 | 10 ± 5 | 170 | 22 | 24 ± 14 | 400 |
rh LIF | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 5 ± 1 | 30 |
rh IL-1α | 56 | 5 ± 2 | nd | 64 | 17 ± 11 | nd | 43 | 6 ± 3 | nd |
All labeling was completely inhibited in the presence of a 100-fold excess of the appropriate unlabeled cytokine.
Abbreviation: nd, not determined because Scatchard analysis was not performed for rh IL-1α.
Sca-1 is identical to Ly6A/E.
Anti c-kit antibody (ACK2) inhibited binding of SCF to c-kit–positive cells. This effect could be partially reversed by acid treating the cells before performing SCF binding.
Mean grain counts ± standard deviations of labeled cells.